181 related articles for article (PubMed ID: 1616651)
1. Cerebrospinal fluid beta 2-microglobulin in patients with AIDS dementia complex: an expanded series including response to zidovudine treatment.
Brew BJ; Bhalla RB; Paul M; Sidtis JJ; Keilp JJ; Sadler AE; Gallardo H; McArthur JC; Schwartz MK; Price RW
AIDS; 1992 May; 6(5):461-5. PubMed ID: 1616651
[TBL] [Abstract][Full Text] [Related]
2. Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, The Netherlands.
Portegies P; Enting RH; de Gans J; Algra PR; Derix MM; Lange JM; Goudsmit J
AIDS; 1993 May; 7(5):669-75. PubMed ID: 8318174
[TBL] [Abstract][Full Text] [Related]
3. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status.
Heyes MP; Brew BJ; Martin A; Price RW; Salazar AM; Sidtis JJ; Yergey JA; Mouradian MM; Sadler AE; Keilp J
Ann Neurol; 1991 Feb; 29(2):202-9. PubMed ID: 1826418
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) p24 antigen levels in HIV-1-related dementia.
Royal W; Selnes OA; Concha M; Nance-Sproson TE; McArthur JC
Ann Neurol; 1994 Jul; 36(1):32-9. PubMed ID: 7912918
[TBL] [Abstract][Full Text] [Related]
5. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
[TBL] [Abstract][Full Text] [Related]
6. CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy.
Valle M; Price RW; Nilsson A; Heyes M; Verotta D
Brain; 2004 May; 127(Pt 5):1047-60. PubMed ID: 15013955
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection.
Brew BJ; Bhalla RB; Paul M; Gallardo H; McArthur JC; Schwartz MK; Price RW
Ann Neurol; 1990 Oct; 28(4):556-60. PubMed ID: 2252366
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic utility of elevation in cerebrospinal fluid beta 2-microglobulin in HIV-1 dementia. Multicenter AIDS Cohort Study.
McArthur JC; Nance-Sproson TE; Griffin DE; Hoover D; Selnes OA; Miller EN; Margolick JB; Cohen BA; Farzadegan H; Saah A
Neurology; 1992 Sep; 42(9):1707-12. PubMed ID: 1355286
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid beta 2-microglobulin in AIDS related central nervous system involvement.
Lazzarin A; Castagna A; Cavalli G; Amprimo MC; Vaj M; Parravicini CL; Costanzi G; Ronchi P; Foppa CU; Moroni M; Turconi R
J Clin Lab Immunol; 1992; 38(4):175-86. PubMed ID: 11270518
[TBL] [Abstract][Full Text] [Related]
10. Immunologic marker paths for seroconversion: single determinations of immunoglobulin A and beta 2-microglobulin are not adequate to estimate time of HIV infection. Multicohort Analysis Project Workshop. Part II.
AIDS; 1994 Jul; 8(7):923-33. PubMed ID: 7946101
[TBL] [Abstract][Full Text] [Related]
11. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain.
McArthur JC; McClernon DR; Cronin MF; Nance-Sproson TE; Saah AJ; St Clair M; Lanier ER
Ann Neurol; 1997 Nov; 42(5):689-98. PubMed ID: 9392567
[TBL] [Abstract][Full Text] [Related]
12. CSF follow-up in HIV-1 infection: intrathecal production of HIV-specific and unspecific IGG, and beta-2-microglobulin increase with duration of HIV-1 infection.
Elovaara I; Nykyri E; Poutiainen E; Hokkanen L; Raininko R; Suni J
Acta Neurol Scand; 1993 May; 87(5):388-96. PubMed ID: 8333244
[TBL] [Abstract][Full Text] [Related]
13. Human immunodeficiency virus-associated dementia: review of pathogenesis, prophylaxis, and treatment studies of zidovudine therapy.
Simpson DM
Clin Infect Dis; 1999 Jul; 29(1):19-34. PubMed ID: 10433561
[TBL] [Abstract][Full Text] [Related]
14. Predictive markers of AIDS dementia complex: CD4 cell count and cerebrospinal fluid concentrations of beta 2-microglobulin and neopterin.
Brew BJ; Dunbar N; Pemberton L; Kaldor J
J Infect Dis; 1996 Aug; 174(2):294-8. PubMed ID: 8699058
[TBL] [Abstract][Full Text] [Related]
15. Laboratory evaluations in HIV-1-associated cognitive/motor complex.
Syndulko K; Singer EJ; Nogales-Gaete J; Conrad A; Schmid P; Tourtellotte WW
Psychiatr Clin North Am; 1994 Mar; 17(1):91-123. PubMed ID: 8190671
[TBL] [Abstract][Full Text] [Related]
16. [Decrease in notifications of AIDS dementia complex in 1989-1990 in Italy: possible role of the early treatment with zidovudine].
Chiesi A; Agresti MG; Dally LG; Zaccarelli M; Tomino C; Floridia M; Vella S
Medicina (Firenze); 1990; 10(4):415-6. PubMed ID: 2099987
[TBL] [Abstract][Full Text] [Related]
17. Effect of zidovudine on cerebrospinal fluid in patients with HIV infection and acute neurological disease.
Hagberg L; Andersson M; Chiodi F; Fuchs D; Svennerholm B; Wachter H; Norkrans G
Scand J Infect Dis; 1991; 23(6):681-5. PubMed ID: 1815328
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 RNA levels in the cerebrospinal fluid may increase owing to damage to the blood-brain barrier.
Burger DM; Boucher CA; Meenhorst PL; Kraayeveld CL; Portegies P; Mulder JW; Hoetelmans RM; Beijnen JH
Antivir Ther; 1997 Apr; 2(2):113-7. PubMed ID: 11322275
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid beta 2 microglobulin in patients infected with human immunodeficiency virus.
Brew BJ; Bhalla RB; Fleisher M; Paul M; Khan A; Schwartz MK; Price RW
Neurology; 1989 Jun; 39(6):830-4. PubMed ID: 2657485
[TBL] [Abstract][Full Text] [Related]
20. Improvement of the predictive value of CD4+ lymphocyte count by beta 2-microglobulin, immunoglobulin A and erythrocyte sedimentation rate. The Multicentre Cohort Study Group.
Schwartländer B; Bek B; Skarabis H; Koch J; Burkowitz J; Koch MA
AIDS; 1993 Jun; 7(6):813-21. PubMed ID: 8103341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
